Join us for an exclusive conversation between Future Cardia CEO Jaeson Bang and Kevin O’Leary (aka Mr. Wonderful) as they discuss how Future Cardia is developing advanced technology to improve cardiac monitoring.
Accelerated by Stanford StartX and incubated at Johnson & Johnson’s JLABS, Future Cardia is leading the charge with cutting-edge technology that provides comprehensive cardiac monitoring—empowering both patients and healthcare providers. With 39 successful human implants and 60,000+ hours of cardiac data collected, the company is delivering unmatched insights for early disease detection.
Hear directly from Jaeson Bang about the company’s vision, and emerging technology in cardiac care that is attracting investor interest.
This product is not yet available for purchase and requires review and clearance before being marketed or sold.
This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Kevin O’Leary is a paid spokesperson for StartEngine. Click here to see his 17(b) disclosure.